Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review
{{output}}
Hairy cell leukemia variant (HCL-v) is a rare and more aggressive subtype of B-cell leukemia. While it shares certain clinical features with classical hairy cell leukemia (HCL-c), HCL-v typically follows a more malignant course and responds poorly to conventio... ...
